Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology.

Eschenhagen T, Force T, Ewer MS, de Keulenaer GW, Suter TM, Anker SD, Avkiran M, de Azambuja E, Balligand JL, Brutsaert DL, Condorelli G, Hansen A, Heymans S, Hill JA, Hirsch E, Hilfiker-Kleiner D, Janssens S, de Jong S, Neubauer G, Pieske B, Ponikowski P, Pirmohamed M, Rauchhaus M, Sawyer D, Sugden PH, Wojta J, Zannad F, Shah AM
Eur J Heart Fail. 2011 13 (1): 1-10

PMID: 21169385 · DOI:10.1093/eurjhf/hfq213

MeSH Terms (17)

Anthracyclines Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antineoplastic Agents Cardiology Cardiotoxins Cardiovascular System Education ErbB Receptors Europe Heart Failure Humans Neoplasms Practice Guidelines as Topic Risk Factors Sirolimus Trastuzumab

Connections (1)

This publication is referenced by other Labnodes entities:

Links